# Local vaccine tie-ups: Now Zydus Cadila has entered into a definitive agreement with Shilpa Biologicals Private Limited to make and supply the ZyCoV-D vaccine drug substance from its integrated biologics centre at Dharwad, Karnataka. Shilpa Medicare also makes Russian vaccine Sputnik V at the same location.

# Covid-19 vaccines on the agenda: As outlined ahead of the talks between the heads of both countries, combating Covid-19 was one of the issues discussed at the meeting between the US President and Indian Prime Minister.

# Call on Roche/Regeneron: The treatment arsenal against Covid-19 just got stronger with the inclusion of Regeneron’s antibody cocktail in the updated guidelines from the World Health Organization. The addition of this two-drug treatment — casirivimab/imdevimab — however, came with a call to companies and governments to address its high price and limited supplies.

# Vaccine On Wheels: A start-up incubated at the Centre for Healthcare Entrepreneurship and IIT Hyderabad has entered into a collaboration with the Telangana Government to support its Covid-19 immunisation drive.

# IIL on course: In line with projections, Immunologicals Ltd (IIL) is set to make Covaxin substance to three million doses per month, and will touch 10 million doses per month by December.

# Maharastra schools: Physical classes in schools would resume across Maharashtra from October 4, the State government has said.

Related Topics
comment COMMENT NOW